Oral answer to question provided on Tuesday, 7 March 2006 in the House of Commons, by Jane Kennedy (Labour), Department of Health.
Colorants
- Answer
-
The addition of small levels of colorants to medicines can often be justified as a way of identifying and distinguishing the different types and strengths of a medicine. That can be very important to patients taking several medicines, for example. However, the use of any substance in a medicine, as well as the drug itself, must be justified under EU legislation before it is granted a marketing authorisation.
Secondary information
- Type
- Oral answer to question
- Reference
- 443 c707
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Additives Colourings Licensing EU law Drugs Prescription drugs Levels
- Link
- View this Oral answer to question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2022-02-16 20:48:05 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787/answer
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787/answer
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787/answer